Zealand Pharma A/S
ZLDPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $49 | $21 | $9 | $6 |
| - Cash | $0 | $0 | $1 | $1 |
| + Debt | $0 | $0 | $0 | $1 |
| Enterprise Value | $49 | $21 | $8 | $6 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -81.7% | 229.6% | -64.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 87.4% | 94.4% | 70.5% | 59.4% |
| EBITDA | -$1 | -$1 | -$1 | -$1 |
| % Margin | -1,632.7% | -191.9% | -639.8% | -243.3% |
| Net Income | -$1 | -$1 | -$1 | -$1 |
| % Margin | -1,720.9% | -205.3% | -928.6% | -348% |
| EPS Diluted | -16.24 | -12.44 | -20.9 | -23.75 |
| % Growth | -30.5% | 40.5% | 12% | – |
| Operating Cash Flow | -$1 | -$0 | -$1 | -$1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$1 | -$0 | -$1 | -$1 |